S. Schlager

发表

Kineticsof Hormone-inducedTumor Cell Resistanceto Killing by Antibodyand Complement1

T. Borsós, S. Schlager, S. Ohanian, 1977 .

Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.

T. Borsós, S. Schlager, S. Ohanian, 1977, Cancer research.

Analysis of the intralesional adriamycin-induced regression of primary and metastatic growth of line-10 guinea-pig hepatoma

D. Goodman, S. Schlager, S. Ohanian, 1980, Cancer Immunology, Immunotherapy.

Stimulation of the synthesis and release of lipids in tumor cells under attack by antibody and C.

T. Borsós, S. Schlager, S. Ohanian, 1978, Journal of immunology.

Use of dyes and radioisotopic markers in cytotoxicity tests.

S. Schlager, A. C. Adams, 1983, Methods in enzymology.

Physical and Chemical Compositionof Subcellular Fractions from Tumor Cells Treated with Metabolic Inhibitors or Hormones1

S. Schlager, S. Ohanian, 2004 .

Radioiodination of cell surface lipids and proteins for use in immunological studies.

S. Schlager, 1980, Methods in enzymology.

Molecular interactions of cells with antibody and complement: influence of metabolic and physical properties of the target on the outcome of humoral immune attack.

T. Borsós, S. Schlager, S. Ohanian, 1978, Contemporary topics in molecular immunology.

Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.

T. Borsós, M. Boyle, S. Schlager, 1977, Cancer Research.

Inhibition of antibody-complement-mediated killing of tumor cells by hormones.

T. Borsós, S. Schlager, S. Ohanian, 1976, Cancer research.

Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells

S. Speck, M. Woisetschläger, S. Schlager, 1996, Journal of virology.

The 'monocytic' cell line I937 displays typical B cell characteristics.

I. Reischl, E. Pöllabauer, M. Woisetschläger, 1996, Immunology letters.

Cell growth-dependent variation in the sensitivity of human and mouse tumor cells to complement-mediated killing.

M. Yamazaki, S. Schlager, S. Ohanian, 1983, Cancer research.

Identification of lipids associated with the ability of tumor cells to resist humoral immune attack.

T. Borsós, S. Schlager, S. Ohanian, 1978, Journal of immunology.

Role of macrophage lipids in regulating tumoricidal activity.

M. Meltzer, M. Mamula, L. D. Madden, 1983, Cellular immunology.

Atomic spectroscopic evidence for the absence of a low-molecular-weight (486) antigen in RNA extracts shown to transfer delayed-type hypersensitivity in vitro.

R. Paque, S. Dray, S. Schlager, 1974, Cellular immunology.

Role of macrophage lipids in regulating tumoricidal activity. II. Internal genetic and external physiologic regulatory factors controlling macrophage tumor cytotoxicity also control characteristic lipid changes associated with tumoricidal cells.

M. Meltzer, S. Schlager, 1983, Cellular immunology.

Separation of cellular phospholipid, neutral lipid and cholesterol by high-pressure liquid chromatography.

H. Jordi, S. Schlager, 1981, Biochimica et biophysica acta.

Relationship between cell-mediated and humoral immune attack on tumor cells. I. Drug and hormone effects on susceptibility to killing and macromolecular synthesis.

S. Schlager, 1981, Cellular immunology.

A role for fatty acid composition of complex cellular lipids in the susceptibility of tumor cells to humoral immune killing.

S. Schlager, S. Ohanian, 1979, Journal of immunology.

Complete local tumor regression with antibody to fibrin Fragment E.

S. Dray, S. Schlager, Sheldon Dray, 1975, Journal of immunology.

Specific 125I-iodination of cell surface lipids: plasma membrane alterations induced during humoral immune attack.

S. Schlager, 1979, Journal of immunology.

Effect of lipids, structural precursors of lipids and fatty acids on complement-mediated killing of antibody-sensitized nucleated cells.

S. Saha, S. Schlager, S. Ohanian, 1982, Molecular immunology.

Tumor cell lipid composition and sensitivity to humoral immune killing. II. Influence of plasma membrane and intracellular lipid and fatty acid content.

S. Schlager, S. Ohanian, 1980, Journal of immunology.

Correlation between lipid synthesis in tumor cells and their sensitivity to humoral immune attack.

S. Schlager, S. Ohanian, 1977, Science.

Ability of tumor cells to resist humoral vs. cell-mediated immune attack is controlled by different membrane physical properties.

S. Schlager, 1982, Biochemical and Biophysical Research Communications - BBRC.

Relationship between cell-mediated and humoral immune attack on tumor cells. II. The role of cellular lipid metabolism and cell surface charge in the outcome of immune attack.

S. Schlager, 1982, Cellular immunology.

Physico-chemical properties of tumor cells that influence their susceptibility to humoral immune killing.

S. Schlager, S. Ohanian, 1979, Biochemical and biophysical research communications.

Physical and chemical composition of subcellular fractions from tumor cells treated with metabolic inhibitors or hormones.

S. Schlager, S. Ohanian, 1979, Cancer research.

Tumor regression at an untreated site during immunotherapy of an identical distant tumor.

S. Dray, S. Schlager, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts.

R. Paque, S. Dray, S. Schlager, 1975, Cancer research.

Tumor cell lipid composition and sensitivity to humoral immune killing. I. Modification of cellular lipid and fatty acid content by metabolic inhibitors and hormones.

S. Schlager, S. Ohanian, 1980, Journal of immunology.

Modulation of tumor cell susceptibility to humoral immune killing through chemical and physical manipulation of cellular lipid and fatty acid composition.

S. Schlager, S. Ohanian, 1980, Journal of immunology.

Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.

S. Schlager, S. Ohanian, 1981, Critical reviews in immunology.

Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid.

T. Borsós, S. Schlager, S. Ohanian, 1978, Journal of immunology.

Effect of hormones on the killing by antibody and complement of tumor cells treated with proteolytic enzymes.

T. Borsós, S. Schlager, S. Ohanian, 1979, Immunopharmacology.

Role of membrane lipids in the immunological killing of tumor cells: II. Effector cell lipids

M. Meltzer, L. D. Madden, S. Schlager, 1983, Lipids.